SCORE

30

OSMT: Osmotica Pharmaceuticals PLC is a Sell


The current rating for OSMT is 30, which is 67% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.